There is no reason to believe they could not be used together. Further studies will be needed to determine if VLA-4 blockade by the monoclonal antibody Tysabri interferes with the ability of an anti-Lingo antibody reaching it’s target in the nervous system.
Rip Kinkel MD
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.